This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
REVIEW UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
SUFU WM 2015
Conferences
Viewing 1-20 of 108 articles
AUA 2020: Identifying the Frequency of Actionable Genomic Alterations in Localized and Metastatic Upper Tract Urothelial Carcinoma
AUA 2020: Pembrolizumab Plus Enzalutamide in Abiraterone-Pretreated Patients With Metastatic Castration-Resistant Prostate Cancer: Updated Results From KEYNOTE-365 Cohort C
AUA 2020: Comparison of Prostate-Specific Membrane Antigen-Targeted Radionuclide Therapy with Lutetium-177 via Antibody J591 vs. Small Molecule Ligand PSMA-617
AUA 2020: Effect of Cabazitaxel vs. Abiraterone or Enzalutamide on Patient-Reported Outcomes in Metastatic Castration-Resistant Prostate Cancer: A Pre-Planned EQ-5D-5L Analysis of the CARD Study
AUA 2020: Abiraterone is Associated with Higher Odds of Cardiac Complications Compared to Enzalutamide
AUA 2020: Inherited Cancer Predisposition Gene Variants in Patients with Non-Muscle Invasive Bladder Cancer
AUA 2020: The Role of the Urinary, Fecal, and Prostatic Microbiome in Prostate Cancer: A Systematic Review
AUA 2020: Pivotal Trial of MRI-Guided Transurethral Ultrasound Ablation in Men with Localized Prostate Cancer: Two-Year Follow-Up
AUA 2020: Decision-Analytic Modeling Study of the PRECISION Trial: Does Pre-Biopsy MRI Do More Good Than Harm?
AUA 2020: Impact of Baseline Disease Volume and Prior Docetaxel Therapy On Prostate-Specific Antigen-Related Outcomes in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated with Enzalutamide plus Androgen Deprivation Therapy
AUA 2020: Surrogate Endpoints for Overall Survival for Patients with Metastatic Hormone-Sensitive Prostate Cancer in the CHAARTED Trial
AUA 2020: Prostate Mapping for Cancer Diagnosis: The Madrid Protocol — Transperineal Prostate Biopsies Combining Micro-Ultrasound and mpMRI Fusion Biopsy
AUA 2020: Cost-Effectiveness of Maintenance BCG for Intermediate and High Risk Non-Muscle Invasive Bladder Cancer
AUA 2020: Is Radiotherapy the Devil’s Work?
AUA 2020: John Duckett Memorial Lecture: Effects of Cancer Treatment in Children into Adulthood
AUA 2020: Benchmarking Current Nephrectomy Practice in Malignant Disease in England: An Analysis of the BAUS Complex Operation Registry
AUA 2020: Expanding Kidney-Sparing Options for Patients with Low-Grade Upper Tract Urothelial Cancer
AUA 2020: Interim Analysis of Phase 2 Randomized Prospective Study on Neoadjuvant Apalutamide/Abiraterone Acetate with Prednisone and the Feasibility of Performing Nerve-Sparing Radical Prostatectomy in Men with High-Risk Prostate Cancer
AUA 2020: Quality of Life of Prostate Cancer Patients with Testosterone Deficiency Symptoms Before Initiation of Gonadotropin-Releasing Hormone Agonist Therapy, Subgroup Analysis of EQUINOXE Study
AUA 2020: Cardiovascular Risk with GnRH Agonists and Antagonists: Real-world Data from UK Primary Care
1
2
3
4
5
6
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free